These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 26945262)
1. 'Sailing in troubled waters': a review of the use of anticoagulation in adult cancer patients with thrombocytopenia. Ibrahim RB; Skewes MD; Kuriakose P Blood Coagul Fibrinolysis; 2016 Sep; 27(6):615-30. PubMed ID: 26945262 [TBL] [Abstract][Full Text] [Related]
2. Anticoagulation Therapy in Patients with Chronic Kidney Disease. Saheb Sharif-Askari F; Syed Sulaiman SA; Saheb Sharif-Askari N Adv Exp Med Biol; 2017; 906():101-114. PubMed ID: 27628006 [TBL] [Abstract][Full Text] [Related]
3. Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy? Laux V; Perzborn E; Heitmeier S; von Degenfeld G; Dittrich-Wengenroth E; Buchmüller A; Gerdes C; Misselwitz F Thromb Haemost; 2009 Nov; 102(5):892-9. PubMed ID: 19888525 [TBL] [Abstract][Full Text] [Related]
4. Nonheparin anticoagulants for heparin-induced thrombocytopenia. Kelton JG; Arnold DM; Bates SM N Engl J Med; 2013 Feb; 368(8):737-44. PubMed ID: 23425166 [No Abstract] [Full Text] [Related]
5. Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus. Napolitano M; Saccullo G; Marietta M; Carpenedo M; Castaman G; Cerchiara E; Chistolini A; Contino L; De Stefano V; Falanga A; Federici AB; Rossi E; Santoro R; Siragusa S; ; ; De Stefano V; Falanga A; Tosetto A; Avvisati G; Carpenedo M; Federici AB; Marietta M; Napolitano M; Rossi E; Santoro C; Castaman G; Cerchiara E; Chistolini A; Contino L; Mazzucconi MG; Nichele I; Russo L; Santi R; Santoro RC; Siragusa S; Tagariello G Blood Transfus; 2019 May; 17(3):171-180. PubMed ID: 30418130 [TBL] [Abstract][Full Text] [Related]
6. Fondaparinux as a safe alternative for managing heparin-induced thrombocytopenia in postoperative cardiac surgery patients. Cegarra-Sanmartín V; González-Rodríguez R; Paniagua-Iglesias P; Santamaría-Ortiz A; Cueva LF; Galán-Serrano J; Moral-García MV J Cardiothorac Vasc Anesth; 2014 Aug; 28(4):1008-12. PubMed ID: 24439171 [TBL] [Abstract][Full Text] [Related]
7. Role of current and emerging antithrombotics in thrombosis and cancer. Mousa SA Drugs Today (Barc); 2006 May; 42(5):331-50. PubMed ID: 16801996 [TBL] [Abstract][Full Text] [Related]
8. Safety of low-dose low-molecular-weight-heparins in thrombocytopenic stem cell transplantation patients: a case series and review of the literature. Ibrahim RB; Peres E; Dansey R; Abidi MH; Abella EM; Gumma MM; Milan N; Smith DW; Heilbrun LK; Klein J Bone Marrow Transplant; 2005 Jun; 35(11):1071-7. PubMed ID: 15821771 [TBL] [Abstract][Full Text] [Related]
10. Effect of unfractionated heparin and low molecular weight heparin on the clotting of platelet-reduced whole blood: an in-vitro study utilizing thromboelastography. Chung J; Stevic I; Gantioqui J; Atkinson H; Chan AKC; Chan HHW Blood Coagul Fibrinolysis; 2021 Jul; 32(5):305-311. PubMed ID: 34231501 [TBL] [Abstract][Full Text] [Related]
11. Vitamin K antagonists in anticoagulant therapy of patients with cancer. Pasierski T Pol Arch Med Wewn; 2012; 122(1-2):60-4. PubMed ID: 22353708 [TBL] [Abstract][Full Text] [Related]